RAG1 and prostate cancer: In our diet-induced hyperinsulinaemic Rag1-/- mouse model [69], we investigated the effect of supraphysiological systemic UAG treatment (100μg/kg/day) on metabolic parameters and PC3 prostate cancer xenograft growth.